Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy

Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonists as Novel Analgesics for Neuropathic Pain: Comparative Pharmacokinetics, Radioligand Binding, and Efficacy in Rats

(2013) Maree T. Smith et al.   PAIN MEDICINE

A Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonist Produces Analgesia in a Rat Model of Neuropathic Pain by Inhibition of p38 Mitogen-Activated Protein Kinase (MAPK) and p44/p42 MAPK Activation in the Dorsal Root Ganglia

(2013) Maree T. Smith et al.   PAIN MEDICINE

Analgesic Efficacy and Mode of Action of a Selective Small Molecule Angiotensin II Type 2 Receptor Antagonist in a Rat Model of Prostate Cancer-Induced Bone Pain

(2013) Arjun Muralidharan et al.   PAIN MEDICINE

Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models

(2012) Peter R. Kamerman et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Raise standards for preclinical cancer research

(2012) C. Glenn Begley et al.   NATURE

The evidence for pharmacological treatment of neuropathic pain

(2010) Nanna Brix Finnerup et al.   PAIN

Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

(2010) Tudor J. C. Phillips et al.   PLoS One

Increased Chemokine Signaling in a Model of HIV1-Associated Peripheral Neuropathy

(2009) Sonia K Bhangoo et al.   Molecular Pain

Ectopic discharge in Aβ afferents as a source of neuropathic pain

(2009) Marshall Devor   EXPERIMENTAL BRAIN RESEARCH

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

(2008) D. M. Simpson et al.   NEUROLOGY

Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain

(2008) Victoria C.J. Wallace et al.   NEUROSCIENCE LETTERS